Skip to main content
Clinical Trials/NCT00406042
NCT00406042
Completed
Not Applicable

The Role of Topical Prednisolone Acetate Following Selective Laser Trabeculoplasty

West Virginia University1 site in 1 country25 target enrollmentSeptember 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glaucoma
Sponsor
West Virginia University
Enrollment
25
Locations
1
Primary Endpoint
Intraocular pressure reduction
Status
Completed
Last Updated
19 years ago

Overview

Brief Summary

To evaluate whether or not using topical steroids after selective laser trabeculoplasty affects intraocular pressure outcomes.

Detailed Description

Subjects undergoing bilateral SLT will be randomly assigned to use prednisolone acetate 1% in one eye four times daily with no treatment in the fellow eye, for one week following SLT. Examinations will occur at baseline, and one week, one month and three months after SLT. IOP and anterior chamber inflammation will be noted at each visit.

Registry
clinicaltrials.gov
Start Date
September 2005
End Date
June 2006
Last Updated
19 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • glaucoma or ocular hypertension
  • need for bilateral SLT

Exclusion Criteria

  • eye disease precluding accurate IOP measurement
  • contraindication to topical prednisolone acetate

Outcomes

Primary Outcomes

Intraocular pressure reduction

Secondary Outcomes

  • Anterior chamber inflammation

Study Sites (1)

Loading locations...

Similar Trials